Ledger.Open graph →
SEC Form D · filed June 6, 2024

Osteal Therapeutics, Inc

Offering
$50.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Dallas, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

David Cash · DALLAS, TXDirectorBrydon Cotter · Vancovuer, British Columbia, CanadaDirectorDarcy Cavanaugh · Vancouver, British Columbia, CanadaDirectorJudson Cooper · DALLAS, TXDirectorRushu Luo · DALLAS, TXDirectorDeborah J. Cotter · Vancouver, British Columbia, CanadaDirectorDavid Thompson · DALLAS, TXExec · DirectorLisa Merage · Newport Beach, CADirectorJustin J. Foo · Vancouver, British Columbia, CanadaDirectorBiren Mehta · DALLAS, TXDirectorBrian De Beaubien · DALLAS, TXDirectorJudson Cooper · DALLAS, TXDirectorDouglas Kohrs · DALLAS, TXDirectorKnox J. Henderson · Vancouver, British Columbia, CanadaExec · DirectorRyan Lewis · Vancouver, British Columbia, CanadaDirectorDouglas Kohrs · DALLAS, TXDirectorSonal Patel · DALLAS, TXDirectorMartin Sands · DALLAS, TXDirectorBiren Mehta · DALLAS, TXDirectorRushu Luo · DALLAS, TXDirectorDavid Cash · DALLAS, TXDirectorMartin Sands · DALLAS, TXDirectorBrian De Beaubien · DALLAS, TXDirectorDavid Thompson · DALLAS, TXExec · DirectorSonal Patel · DALLAS, TXDirectorSean Wagner · New York, NYDirectorFred Brown · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗